FWM
VYNT

Frontier Wealth Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Frontier Wealth Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$184K Hold
40,520
– – 0.01% 370
2022
Q1 		$229K Hold
40,520
– – ﹤0.01% 352
2021
Q4 		$274K Hold
40,520
– – 0.02% 344
2021
Q3 		$472K Hold
40,520
– – 0.03% 274
2021
Q2 		$758K Buy
+40,520
New +$755K 0.05% 210

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
CCB
Country Club Bank Kansas City, Missouri $1.69B AUM 16.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Frontier Wealth Management's VYNT Position: Q2 2022 in Review

Frontier Wealth Management held its Vyant Bio, Inc. Common Stock (VYNT) position steady in Q2 2022 at 40,520 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #370.

Frontier Wealth Management first reported a position in VYNT in Q2 2021 and has held it in 5 quarters since. The position peaked at $758K in Q2 2021. 21 funds tracked by Wall St. Rank hold VYNT as of Q2 2022.

  • Frontier Wealth Management held 40,520 shares of Vyant Bio, Inc. Common Stock worth $184K as of Q2 2022.
  • Frontier Wealth Management left its Vyant Bio, Inc. Common Stock share count unchanged in Q2 2022.
  • Vyant Bio, Inc. Common Stock made up 0.01% of Frontier Wealth Management's portfolio in Q2 2022, its #370 holding.
  • Frontier Wealth Management first reported a position in Vyant Bio, Inc. Common Stock in Q2 2021 and has held it in 5 quarters since.
  • Frontier Wealth Management's Vyant Bio, Inc. Common Stock position peaked at $758K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.